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Abstract 
The United States experiences opioid addiction at epidemic levels. In 2012, the National 
Institute of Drug Abuse reported that 23.1 million Americans were in need of addiction 
treatment services, although only 2.5 million were enrolled in treatment. Following an 
amendment to the Drug Addiction Treatment Act of 2000 (Public Law 106-310), advanced 
practice nurses were qualified as providers who could bridge the healthcare gap in treatment 
access. The purpose of this project was to determine the interest of advanced practice nurses in 
(a) prescribing buprenorphine and (b) establishing guidelines that would allow them to do so. 
This quantitative project used a 10-question Internet-based survey with a convenience sample of 
95 nurses (recruited online) who were currently practicing in advanced nursing roles. Social 
media platforms, including Facebook, were used to recruit participants. The survey included 
questions about expanding the scope of practice in addiction treatment and establishing 
guidelines that would allow nursing knowledge and expertise to be used in outpatient opiate 
addiction treatment. Critical social theory and Kingdon’s theory of policy analysis were applied 
to support the project. The Survey Monkey data analysis tool was used to generate descriptive 
statistics, which demonstrated respondents’ support for an expanded scope of practice. If the 
recommendations of this project are adopted by national legislation, increased accessibility to 
addiction treatment services will save millions of dollars in justice system, healthcare system, 
employment, and societal costs. Nursing policy advocates nationally can apply these results to 
support efforts to expand scope of practice to include prescribing buprenorphine
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Section 1: Overview of the Evidence-Based Project  
                                           Introduction 
In 2014, the United States healthcare system introduced the Affordable Care Act 
(ACA), which mandated healthcare coverage for millions of Americans (Manchikanti & 
Hirsch, 2012). The introduction of ACA has seen an influx of over 4 million newly insured 
patients into a system that is already experiencing a shortage of primary care providers. One 
proposed solution to cope with the predicted shortage of primary care providers is allowing 
already practicing advanced practice nurses (APNs) to practice to the maximum extent of their 
education (Bodenheimer & Hoangmai, 2010). The Children’s Health Act of 2000 allowed 
APNs to practice within a very limited scope, which varies from state to state. Despite their 
advanced education, APNs’ scope of practice has been limited by many old healthcare policies 
that have not changed over the years to match the advancement in APN roles (Pohl et al., 
2010). 
The Robert Wood Johnson Foundation (RWJF; 2012) identified the fact that APNs 
have been confined to strict clinical barriers guarded by the American Medical Association 
(AMA). The AMA justifies these barriers as a patient safety measure. 
Medical boards and legislators continue to enact scope of practice barriers for APNs 
(RWJF, 2012). Many states have instituted MD/APN collaborative agreements. These 
agreements ensure that every practicing APN is either directly or indirectly supervised by a 
licensed physician to ensure patient safety. Nursing leaders and advocates have taken the lead 
in challenging these clinical barriers, citing the need to utilize APNs fully (RWJF, 2012). The 
Institute of Medicine (IOM; 2010) also sees the need for nurses to “practice to full extent of
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of their education and training” (AACN, 2006, para. 6). Policy makers and Congress have 
remained silent on the clinical boundary and scope of practice issues, having enacted some of 
the policies that are the barriers to practice. A specific policy that will be addressed in this 
project is the Drug Addiction Treatment Act 2000 (DATA 2000), which has barred NPs from 
prescribing buprenorphine, the only Federal Drug Administration (FDA) medication approved 
for the treatment of opioid addiction in outpatient settings House Resolution 4365( DATA 
2000). 
This DNP project is based on the American Association of Colleges of Nursing (AACN) 
Essentials of Doctoral Education for Advanced Nursing Practice, Item 5, called Health Care 
Policy for Advocacy in Health Care (AACN, 2006). The AACN (2006) has identified the need for 
nurses to engage in creating a healthcare system that meets the needs of the consumer through 
policy development and policy change. Nurses need to be involved actively in political lobbying 
and activism for policy development and change. The DNP-prepared nurse has the ability and 
education to evaluate, design, influence, and implement health care policies—in short, to lead the 
policy change process (AACN, 2006).. DNP graduates are prepared to identify healthcare needs 
and lobby for changing policies that perpetuate social injustice and inequality in health care 
(AANC, 2006). A combination of systems thinking and social justice principles enhance the need 
to identify NPs’ perceptions about prescribing narcotic medications for all their patients—a policy 
that is in need of examination and possible future amendment. Critical social theory and 
Kingdon’s theory of policy analysis supported the project and the policy analysis approach. 
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Statement of the Project Problem and Target Population 
The problem in this project is the lack of access to care and treatment for patients with 
opiate abuse problems. The health promotion and disease prevention issue is opioid addiction 
and abuse. The purpose of objective SA-8.1 Healthy People 2020 (HP2020) is to “increase the 
proportion of persons who need illicit drug treatment and receive specialty treatment for abuse or 
dependence in the past year" (HHS, 2010, p. 12). This objective is aimed at improving access to 
treatment for persons with substance abuse problem. The targeted population is anyone over the 
age of 12 years involved in illicit opioid drug use. Data from the NIDA(2012) showed a steady 
increase in people who needed addiction treatment, indicating that a total of 23.1 million 
Americans (8.9%) need addiction treatment but only 2.5 million (1%) are currently enrolled in 
addiction treatment. .The number of people who enrolled in the program increased only slightly 
from 16% in 2008 to 18.8% in 2011(HHS, 2010). The ACA is intended to improve access to care 
and will likely further increase patient need for enrollment in drug abuse programs. APNs should 
be able to prescribe buprenorphine without limitations if the U.S. is to meet the HP2020 target 
(HHS, 2010). 
Background 
The Office of National Drug Control Policy (2011) reported that substance abuse is 
currently an epidemic in the United States. Irresponsible use of illicit and prescription drugs has 
resulted in many deaths and hospitalizations costing billions of healthcare dollars. Substance 
abuse impacts individual users, their families, and the community as a whole due to lost 
productivity of these individuals and justice system costs. The National Institute of Drug 
Abuse (NIDA, 2011) estimated that approximately 95% of active substance abusers are in 
denial or unaware of their problem. “Of those who recognize their problem, 273,000 have 
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made an unsuccessful effort to obtain treatment.” HP2020 stressed the necessity of improving 
access to treatment for substance abuse and other health disorders. 
In 2006, the American Academy of Nurse Practitioners (AANP) published a position 
paper documenting the quality of NP practice. The paper outlined the progress that APNs have 
made over time in training and knowledge. It encouraged APNs to maximize their education and 
healthcare knowledge while helping to bridge the primary care gap. AANP’s efforts to advance 
and broaden APNs’ scope of practice have sparked several professional debates between nurses 
and other professional colleges. Nevertheless, these efforts have set in motion a change process 
that will advance nursing as a profession. 
Drug Addiction Treatment Act 2000 
Title XXXV, Section 3502 of the Children’s Health Act of 2000 (The Children’s Health 
Act of 2000) permits only physicians who meet certain qualifications to treat opioid addiction 
with Schedule III, IV, and V narcotic medications. APNs are prohibited from prescribing these 
drugs. DATA 2000, which is at the federal level, prohibits NPs from prescribing Subutex and 
Suboxone (buprenorphine), which are Schedule III, IV, or V medications; while in some states 
with in the United States (http://www.aanp.org/legislation-regulation/state-legislation-
regulation/state-practice-environment), the laws allow APNs to prescribe Schedule III, IV or V 
medications. Since the state law is contradictory to the federal law, state legislatures have been 
forced to specify that only “qualified physicians” are allowed to prescribe buprenorphine. This 
provides accommodation for the federal policy prohibiting APNs from prescribing Subutex 
and Suboxone (Cunningham et al., 2007). This has led to questions about the rationale, 
purpose, and validity of the federal legislation. Currently, there are over 100,000 NPs who are 
authorized at the state level to prescribe Schedule III drugs/ medications, such as oxycodone 
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and OxyContin, which may cause addiction; but they are prohibited by federal law from 
prescribing medication in the same class that can be used to treat opioid addiction, such as 
buprenorphine. 
APN Scope of Practice and Prescriptive Authority 
The APN scope of practice allows for patient health assessment, disease diagnosis and 
treatment, health education, preventive healthcare, research, prescriptive authority, and much more 
(Sheer & Wong, 2008). APNs have played a crucial role in meeting provider shortages in the rural 
and underserved areas (Agency for Healthcare Research and Quality, 2012). However, states have 
shown disparity in the legal autonomy of APNs to practice and to prescribe. The National Council 
of State Boards of Nursing introduced the consensus model aimed at helping states achieve a 
uniform APNs’ scope of practice and independent prescribing. This model has been adopted by 
several states and remains in the legislative process in other states. The prescriptive authority of 
APNs varies greatly from state to state; partly because of the practice environment which varies 
from state to state (AACN, 2006). 
APNs’ narcotic prescriptive authority varies in each state according to the schedule of the 
drug, with some states allowing wider prescriptive scope than others. Florida and Alabama allow 
APNs to prescribe limited selection of controlled medications only, 19 other states allow APNs to 
prescribe Schedule II to IV drugs, while 10 additional states allow APNs prescriptive authority for 
Schedule III and IV controlled substances (AANP, year). This variation is questionable as the 
level of educational preparation for APNs is either the same or comparable across states and is 
regulated nationally through program accreditation. Buprenorphine, which is the only FDA 
approved medication for the treatment of opioid addiction, within the primary care setting. 
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APN Education 
APNs have strived to attain the highest level of education for the sake of their career. 
The AACN (2012) recommended the DNP as the terminal degree for APNs, beginning in 2015. 
This has been an issue for a national discussion among healthcare professionals but with the 
increasing numbers of DNP-prepared nurses, the profession is well poised to align education 
and clinical practice with other doctorally-prepared colleagues in healthcare. 
Political Environment 
The political environment in the United States has some impact on determining the 
APN scope of practice through policy writing and implementation. The Agency for Healthcare 
Research and Quality (2012) acknowledged that, with the current primary care provider 
shortages, especially in light of healthcare reform coverage expansion in 2014, a review of the 
state laws in reference to APN scope of practice is a way to increase primary care’s ability to 
absorb new patients as well as offer addiction treatment services. A recent National Governors 
Association report (2012) encouraged states to consider liberalizing the state scopes of practice. 
This would allow APNs more autonomy to practice and meet the current shortage of primary 
care services. APNs authority ability to practice more broadly will likely take considerable 
advocacy efforts to attain accomplish independent or wider scope of practice for APNs due to 
the variable scope of practice in each state (Agency for Healthcare Research and Quality, 
2012). However, DATA 2000 remains a legislative act, which unless changed, will not allow 
APNs to be able to treat patients appropriately with opioid addiction. There is currently no 
documented rationale for DATA 2000 although the American Medical Association (AMA) has 
openly opposed the integration of APNs in opiate addiction treatment as prescribers. 
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Mission Statement, Goals, and Objectives 
Stakeholders are individuals or organizations that have a vested interest in the project and 
will directly influence the project outcome. In the planning process, it is important to identify 
and establish stakeholders who align with the project purpose. The opposing stakeholders may 
likely cause unnecessary anxiety and confusion although their opinion and rationale are welcome 
to provide input for the project. 
In expanding the role of APNs in addiction treatment, the stakeholders must be people 
who have a passion for addiction work and are or have been affected by addiction. Because 
addiction affects the whole community, there is a need to involve stakeholders such as community 
leaders, church leaders, law enforcement officials, local public policy makers, and patients/ 
families affected by addiction. Stakeholders play an important role in planning meetings, 
community surveys, and community assessments. They also help by sharing their opinions, acting 
as community liaisons, lobbying for policy change, and educating the community on the need for 
change. As stakeholders, community leaders, church leaders, law enforcement officials, NP 
organizations, legislative representatives, and patient representatives can assist in the development 
of this DNP project’s mission, goals and objectives so that they are in line with the community 
need and readiness for the change.   
As part of the DNP project, information was gathered that will facilitate amendment of 
the statute (DATA 2000), which has favored physicians over NPs in the prescription of 
buprenorphine. While this project will likely receive support from the community and law 
enforcement officials who are eager to increase addiction services and decrease addiction-related 
consequences, the project will likely meet resistance from physicians and their professional 
organizations. The end product of the project will be a set of guidelines that would allow APNs 
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to qualify to prescribe buprenorphine, guidelines that can be presented to the federal legislators 
for review and adaptation in order to amend DATA 2000. Feedback on these guidelines from 
practicing APNs and nursing professional organizations will be vital in this effort. 
Purpose of the Project 
The purpose of the project was to describe APNs’ (a) perceptions of current federal 
legislation (DATA 2000) restricting prescriptive authority associated with buprenorphine for 
outpatient opioid addiction treatment, (b) opinions regarding the qualifications of APN 
education and expertise needed for prescribing buprenorphine, (c) feedback on author-
developed guidelines that would qualify APNs to prescribe buprenorphine, and (d) personal 
interest in prescribing buprenorphine. The outcomes of the project, when achieved, will increase 
accessibility to opioid addiction treatment services through effective utilization of APNs as 
prescribers. 
Project Goal 
There is a need to expand addiction treatment services. NIDA (2012) that addiction id 
currently costing the United States over 484 billion dollars annually with only a fraction of 
substance abusers enrolled in treatment. APNs are well situated to bridge the gap. The goal of 
this project was to gather information that will provide evidence for, and facilitate the 
amendment of, DATA 2000; the ultimate goal is to advance the role of APNs by expanding 
their scope of practice to allow them to provide safe, timely, and cost-effective treatment of 
opioid addiction within the office practice setting. 
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Objectives 
 
1. Gather U.S. APN participants’ responses to an online survey to give their opinion on 
guidelines and suggested APN qualifications for prescribing buprenorphine, 
2. Analyze APN participants’ feedback to determine level of support on a guideline 
that would allow APNs to qualify to prescribe buprenorphine, and 
3. Identify APN interest in prescribing buprenorphine.   
                               Project Activities 
The project was limited to an electronic survey submitted to APNs in the United States. 
Respondents were recruited randomly via e-mail and through posts on APN pages on 
Facebook. The survey results were available for review on Survey Monkey; hence, there was 
no need for participants to return the completed survey by mail. The survey period was 
limited to 3 weeks. The two project activities were as follows: 
1. Develop an online survey to elicit APNs’ opinion on the guidelines for qualifying APNs 
to prescribe buprenorphine. 
2. Analyze the survey data to determine acceptability of the proposed guidelines to 
practicing APNs. 
The AANP has a vision to expand the scope of NP practice and maximize their potential in 
clinical practice. The AANP believes that NPs’ education and experience will translate into great 
benefits to patients by provision of superior healthcare and improved patient access to care. The 
intended result of the project was data that could be used to support political efforts to expand the 
scope of practice for APNs that would result in more patients enrolled in addiction treatment and 
additional access to appropriate medications. This project has the capacity in the future to 
positively impact social change resulting in improved quality of life for patients and families and 
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decreased criminal justice burden associated with addiction, as well as save healthcare dollars 
spent on addiction. 
                       Assumptions and Limitations 
The limitations identified for this project included the time limit for the study; this 
might have limited the possibility to gaining access to a larger group of participants or 
participants in certain geographic areas. The survey aimed at a randomized sample although 
the respondents may not be truly be a random sample as they were targeted through certain 
criteria, The study results were based on assumption that the responses provided were truthful 
and honest. The results were generalized to APNs within the U.S although some state had very 
low response. This is based on assumption that their opinion is representative of all practicing 
APNs. 
Definition of Terms 
The following terms are defined for the purpose of this study. 
Narcotics are drugs that require a prescription from a licensed provider with a valid 
federal DEA number (Samsha.gov). 
Advanced practice registered nurses (APRNs)/Nurse practitioners (NPs) are nurses 
defined by the AANC describes this as having completed master’s level education in nursing and 
passing a national licensure examination. In this paper, they are referred to as APNs (ANA, 
2006). 
Buprenorphine is a narcotic analgesic that is derived from thebaine and is administered 
in the form of its hydrochloride, which is administered for the treatment of moderate to severe 
pain or to treat opioid dependence (SAMHSA.gov) 
11 
 
 
Suboxone is a FDA-approved prescription formulation of buprenorphine 
commonly used for the treatment of heroin addiction and opioid dependency 
(SAMHSA.gov). 
Subutex is the same as buprenorphine defined above (SAMHSA.gov). 
Prescriptive authority is “the ability of advanced practice registered nurses (APRNs) 
to prescribe, without limitation, legend (prescription) and controlled drugs, devices, adjunct 
health/medical services, durable medical goods, and other equipment and supplies” (AANP, 
2007b, para. 4). 
Opioid addiction is a person’s inability to refrain from the use of narcotics regardless 
of detrimental effects and no benefits. The addiction may be to prescribed or illegal opioids 
(Galea, 2004). 
Social factors are factors that cause disparity in healthcare services and create a barrier 
to patient care (Parks et al., 2008). 
Political and legal factors are factors that uphold federalism and may create 
conflicts between federal and state regulations in reference to APN scope of practice 
(AANP, 2007b). 
Scope of practice is “the who, what, where, when, why, and how of nursing 
practice, including advanced practice nursing” (AANP, 2007b, para. 2) 
Summary 
DNP graduates are adequately prepared to identify healthcare needs and lobby for change 
of policies that perpetuate social injustice and inequality in health care (AANC, 2006). A 
combination of systems thinking and social justice led to the development of a 
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project to amend a national law (DATA, 2000) that is not supported by evidence and 
limits the ability of APNs to practice to the full extent of their education and licensure. Section 2 
is the review of literature. This section will discuss the project’s framework and policy analysis. 
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Section 2: Review of Literature, Concepts, Models, Theories and Framework 
Introduction 
The purpose of the project was to describe the current trends in the continuing 
development of guidelines that would allow APNs to prescribe buprenorphine in treating opioid 
addiction on an outpatient basis. This section of the project examines previous studies theoretical 
framework, and APN roles. The purpose of the project was to describe the current trends in the 
continuing development of guidelines that would allow APNs to prescribe buprenorphine in 
treating opioid addiction on an outpatient basis. 
Search Strategy To identify the relevant data, the following databases were used: 
PubMed, CINAHL, and PsycINFO. The following keywords were used: nurse practitioner, 
scope of practice, addiction treatment, DATA 2000, and opioid addiction. The literature 
review was limited to foundational, seminal and peer review articles published within the last 
10 years. 
The International Nurses Society on Addictions (IntNSA) wrote a position statement on 
DATA 2000 (2011) and identified DATA 2000 as a barrier to treatment and recommended its 
amendment. According to IntNSA, to provide accessible, safe, buprenorphine treatment for 
opioid addiction treatment, DATA 2000 needs to allow APNs who meet the criteria and express 
a desire to prescribe buprenorphine in outpatient treatment centers (OPTs) to do so. The 
Association of Nurses in AIDS Care (ANAC; 2011) shared this position and noted that 
amendment would increase access to treatment and reduce the current addiction related 
problems. 
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Due to societal problems that come with addiction, the need for access to treatment was 
studied by the National Center on Addiction and Substance Abuse (CASA) at Columbia 
University, identified a great rift that separates the people affected by substance abuse from those 
receiving treatment ( NIDA, 2012). In its study, CASA learned that almost 1,000,000 people 
within the criminal justice system in the U.S. are in need of addiction services, yet less than 25% 
of that population actually received them. Healthy People 2020 (HP2020) estimated that the 
United States has lost $600 billion annually in healthcare costs and criminal justice expenses as 
well as lost productivity due to addiction. HP2020 agreed that expanding addiction services will 
have a significant positive impact on the reduction of this addiction related burden (HHS, 2010). 
NIDA published Principles of Drug Addiction Treatment (2011) that indicated a need for 
diversity in addiction treatment. The Institute identified that there is a promising future for 
addiction treatment options, which will decrease the addiction disparity as well as the financial, 
criminal and healthcare burden associated with it (Pearson, 2012). 
NIDA (2011) in their statement agreed that substance abuse is a major burden to 
society and reported that the costs of drug abuse and addiction are steadily on the rise in the 
U.S. Hospitals are spending about one dollar of every four Medicare dollars on inpatient 
treatment of addiction related services. Approximately 70% of incarcerated individuals within 
the prison system regularly abuse illegal substances (NIDA, 2011). 
NIDA (2011) reported that the cost of addiction treatment is greater than the cost of all 
diseases of the brain combined. Drug addiction treatment services have been shown to have a 
positive impact, but a lack of these services creates a continued burden for the healthcare system, 
the justice system, and society. Available treatments like methadone and buprenorphine are 
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effective in eliminating addiction and enabling a more productive community (Pearson, 2012). 
APNs are currently not authorized to prescribe methadone although addiction treatment with 
methadone is restricted to specialized clinics and cannot to provide in primary care office. 
Research has shown that for every dollar invested in addiction treatment there is a return of $5–
10 in healthcare spending savings. The United States, through HP2020, has established an 
objective to decrease addiction related burden and the many effects it has on the community 
and the country as a whole (HHS, 2010). 
Theoretical Framework 
Nursing knowledge, research, and practice development are guided by theoretical 
frameworks. This project reflects healthcare policy analysis and advocacy as outlined by AANC 
(2006). The two frameworks are presented to advance and promote policy change as well as 
social justice advocacy. 
Critical Social Theory 
DATA 2000 is a public health policy that affects the abilities of patients with 
opioid addiction to access and effectively engage in health-enhancing healthcare/ treatment. The 
selected theory to address this problem is the CST. CST is a sociological theory that identified 
and addressed oppressive social and societal issues. Calhoun (1995) reported that CST is a theory 
used in societal awareness to expose inequalities within the society that have prevented people 
from reaching their full potential. This theory was selected because addiction is a social problem, 
and DATA 2000 has prevented patients from accessing much needed treatment. 
In sociology, CST has been used by students to critique policies within the institutions 
that are viewed as oppressive. CST has also been used in nursing to support practices to address 
oppressive sociopolitical issues and policies influencing health and health care such as DATA 
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2000 (Calhoun, 1995). McEwen and Wills (2011) identified that CST has been useful to 
nursing when working with disadvantaged groups. They identified an example of limited 
access to mental health services whereby the CST was used to empower individuals to action 
for change. As with mental healthcare, this theory can be applied to addiction treatment to 
guide stakeholders to initiate action for change and enhance access to addiction treatment. 
McEwen and Wills (2011) agreed that the healthcare system and organizations are not 
designed with proper communication channels between healthcare consumers and healthcare 
policy makers. This lack of communication reduces negotiation opportunities because the 
agencies maintain authority resulting in policies that patients may view as biased or oppressive 
such as access to care issues. The CST will be used in the project to identify and outline the 
biased and oppressive aspects of DATA 2000. 
Kingdon’s Theory in Policy Analysis 
Kingdon’s theory offered a framework for agenda setting in the policy process. Figure 1 
provides an overview of the stages of Kingdon’s theory in policy analysis. The initial stage of 
the policy agenda provides an outline of problems for the government officials and stakeholders 
to review. In this project, opioid addiction was identified as a problem that needs to be 
addressed through policy change to ensure effective solutions. This stage provides a 
foundation for moving the policy proposal by following a sequence of changing problems to 
proposals and then initiating changes through politics (Milstead, 2011). This problem 
advancement process is crucial in persuading policy makers and stakeholders to give the issue 
the attention it deserves. Guidelines were developed in this project to guide APNs interested 
in prescribing buprenorphine prescription. There is also a policy brief; this will be a key 
instrument when persuading policy makers for change. The policy brief will enable the 
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problem of addiction to be presented as an actual or potential crisis through available data, 
and previous or potential events or public concerns (Milstead, 2011). 
The policy proposal is the presented agenda of the proposed problem change. The policy 
is outlined, reviewed, revised, debated and accepted for consideration by lawmakers. A policy 
brief is useful in providing an overview of the issue at hand (Milstead, 2011). The policy 
proposal must be seen as feasible, acceptable to policy makers, meeting public needs and cost 
effective goals. Using the policy brief developed through this program, the presenter of the 
agenda should identify policy makers whose values are in line with the proposed change to rally 
their support and provide the document as a guide to further educated them on the issue 
presented (Milstead, 2011). 
Politics involves the problem advancement stage where the lawmakers and 
stakeholders’ advocacy groups and provide the climate mood to ensure a synchronized voice for 
change. The agenda setting must take place when the political climate is ready for a change 
(O'Connor, 2010). This is probably a great time for political changes as America works to 
embrace the healthcare reform. The project can be replicated in the future, and the data 
collected presented as evidence to set the agenda stage. 
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Figure 1. An overview of the stages of Kingdon’s theory in policy analysis. (Adapted From 
“Beyond Simple Pessimism,” by D. Keltner, P. D. Ellsworth, and K. Edwards, 1993, Journal 
of Personality, 64, p. 751. Copyright 1991 by the American Psychological Association. 
Adapted with permission of the author.) 
Summary 
The presentation of the problem and the burden it entails is the initial stage of problem 
advancement. Any policy proposal must be brief, easy to understand, organized and convincing 
to policy makers. The pros and cons of the legality of NP prescription of buprenorphine to 
improve care reduce addiction prevalence and decrease the addiction related burden to the 
healthcare system, the justice system, and the community must be presented objectively. The 
policy proposal will be crucial in rallying support from lawmakers, state boards of nursing, 
professional organizations, community leaders and patients and their families. Influential 
constituents must be involved to provide a voice for the patients. Financial responsibilities and 
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possibilities involved must be presented accurately to outline the costs and benefits of the 
policy change (Milstead, 2011). 
The final stage is the politics involved. This stage will include policy makers 
supporting or declining to support the change (Milstead, 2011). The change provided in the 
proposal if presented well and reflecting accurately the societal disposition (literature review 
findings and APNs’ beliefs from the survey) and the policy stream ( public acceptance, 
feasibility, and value convergence) should make the politics stage easier. This final stage 
although important will be completed in the future. This project set the stage by collecting and 
analyzing data which when presented in the future will support and ensure this proposed 
policy change.  
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Section 3: Approach and Methodology  
Introduction 
The purpose of the project was to describe the current trends in the continuing 
development of guidelines or criteria that would allow APNs to prescribe buprenorphine in 
treating opioid addiction on an outpatient basis. The project is considered feasible because the 
resources, nursing and community support the initiative. Although many patients are already in 
treatment, many more remain unable to get treatment. Among the factors involved in the 
treatment disparities, access to treatment is a major concern. Many APNs have expressed a desire 
to prescribe buprenorphine. Patients have been receptive to care provided by APNs, and this 
proposed expanded scope of practice not likely be an exception. It is, however, unknown but 
rather hypothesized that this initiative will lead to a decrease in crime. The medical 
establishment has opposed this amendment in the past and will likely continue to erect a barrier 
to the proposed legislative change. Like with every healthcare issues, addiction is not an 
exception. Addiction requires collaboration of healthcare professionals to initiate positive change 
and decrease the related burdens. 
Chronic health problems have shown to be very expensive to manage. Addiction-related 
issues cost America billions of dollars. This initiative is projected to possibly reduce healthcare 
and criminal justice system spending as well as decrease emergency room visits. APNs have an 
interest in treating addiction to help decrease the disparity. In some states, APNs already hold a 
valid DEA number so the training related costs will be minimal. As part of guideline 
development, I would if policy change is initiated, recommend that APNs be required take the 
same 8-hour course taken by physicians to qualify them to prescribe buprenorphine. With most 
healthcare change projects, cost is usually a factor of concern. It is crucial to make financial 
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sense of the project to ensure support. The amended law will increase accessibility to cost-
effective treatment by expanding the number of providers who can prescribe appropriate 
treatment for patients with opioid addiction who sought treatment. 
Implementation Plan 
The implementation plan is important for ensuring that the study objectives are met. For 
this DNP project, the objective is to (a) invite APNs to participate in an online survey to give 
their opinion on developed guidelines and suggested APN qualifications for prescribing 
buprenorphine and (b) analyze APN participant’s feedback to determine the level of support and 
finalize the guidelines that would allow APNs to qualify to prescribe buprenorphine. The 
information collected in this study will be used in the future to sought to expand the role of NPs 
to ensure increased accessibility to addiction treatment, decreased prevalence of opioid 
addiction in the U.S. The project allowed for a virtual interface without costly face-to-face 
meetings. Online/Internet surveys were be transmitted electronically to APN participants who 
responded anonymously. The responses were accessed online by this author. Data obtained 
were analyzed, and conclusions drawn to change the guidelines as necessary in accordance with 
APN input. A policy brief was developed based on the responses and the literature review. 
Budget 
Rabinowitz (2010) outlined the importance of a comprehensive budget that includes the 
program activities, manpower needs and all other expenses associated with the project. The 
project involves data collection through emails and social network. Expenses/ projected costs 
will only be estimated based on time spent on the project. There are currently no identified 
external sources of funding. Table 1 shows the anticipated project expenses. The actual 
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implementation and policy change will be done in the future and is not part of this DNP 
project. 
Table 1 
    
Project Budget. 
 
 Time  
(hours) 
Cost of  
time/hr. 
Total 
cost 
Project development and evaluation 50 $100 $5,000 
(Planning, literature review, proposal, and 
IRB approval, survey development). 
   
Implementation and data analysis 40 $100 $ 4,000 
Total cost 90  $9000 
 
There was a focus on low-cost interventions to minimize the project cost. Cost of the 
project was calculated based on a time value so there were no actual expenditures to conduct 
the project. Healthy People (2020) reported that addiction currently costs the United States an 
estimated $600 billion annually in healthcare, lost productivity, and drug-related crime cost 
(USDHHS, 2010). If accessibility to treatment is not improved that cost may be higher. It is, 
therefore, important that the problem of addiction is addressed. Short-term implications of 
APN prescription of buprenorphine include a rise in costs due to increased numbers of 
patients being treated, whereas long-term implications may be the decreased burden of drug 
abuse on the community, the justice system, and the patients and their families. Preventable 
loss of life related to addiction is also a reason to address the problem. 
To address a federal policy, the political model is most appropriate. The political 
model is a flexible budgetary method that allows for negotiations. In this model, stakeholders 
come together and agree on a compromise (Kettner, Moroney, & Martin, 2013). DATA 2000 
is a policy that has seemed to favor one profession above other negotiations are, therefore, 
very necessary. This process calls for stakeholders to rally the community and political 
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leaders to seek support in the acquisition of funds and resources to support the policy change. 
Stakeholders have a role in resource allocation to ensure that the community needs are met 
(Kettner et al., 2013). Initiating change in a policy that is years old and protects the vested 
interests of one profession needs strong stakeholder involvement. Professional organizations, 
community leaders, NPs, boards of nursing, and political leaders will each have a role to play 
in advocating for a policy change (Kettner et al., 2013). This DNP project collected data to 
demonstrate to stakeholders the level of APNs’ interest in treating opioid addiction. 
Data Collection Methods 
Data collection for this project was derived from one-survey instrument that was 
developed by this author. A simple online survey was developed to determine whether APNs 
continue to desire to prescribe buprenorphine and their reactions to the developed guideline 
for APN prescriptive authority for this drug. The development of the guidelines was directed 
by information from the state and federal drug addiction treatment guidelines that have to be 
met by physician providers authorized to prescribe buprenorphine.  
Upon approval from the Walden University Institutional Review Board (IBR), the 
survey was distributed to participants. Instruments from scholarly websites and nursing 
practice were considered for use, but, this author developed the specific questions that were 
posted on social media like Facebook to reach APN participants. Social media allowed the 
author to reach participants from all over the U.S. The link was specifically posted to APN 
group pages. The link to the survey was also emailed to APNs. 
The survey was made available via Survey Monkey to increase accessibility and 
availability as well as easy transmission of APNs’ responses, comments, and observations. 
Demographic questions were used to classify the participants by APN specialty. It was 
important to this author to ensure that a good portion of respondents were APNs currently  
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practicing in the U.S. As part of the survey, feedback was solicited to measure the perceived 
value of the project and the perceived need for the project by the targeted nursing 
professionals. Besides completing the survey, some of the participants posted their views or 
questions about the project on Facebook. 
                                    Pilot Survey Tool 
The survey was piloted to determine face validity of the survey, the readability of the 
questions, and the ability of the questions to elicit informative responses. The piloting of the 
survey ensured that the tool was acceptable to APNs, and understandable and easy to interpret 
by NPs practicing in different states. The pilot test elicited feedback from five APNs. The 
feedback from the pilot of the survey was used to develop the final web-based survey 
instrument. Through the pilot survey, it was revealed that some of the responses had to be 
adjusted to illicit uniform response. Free text answers were eliminated.  
Test-retest reliability was conducted using five NPs to complete a Web-based survey 
to be sent via e-mail. The same survey was later sent to the same NPs 2–3 weeks later 
following IBR approval. The responses were analyzed for agreements, omissions and any 
additions or suggestions. The survey instrument, which is now closed, was available at   
https://www.surveymonkey.com/s/PY669KC. The final survey was a refined version of the 
pilot survey; the format included 10 questions regarding the content of the developed 
guidelines for prescriptive authority qualifications. The questions on the survey as well as 
specific responses elicited will be discussed later in this report. The data were then 
analyzed, and a final project report in the form of a policy brief was developed for nurse 
policy advocates to use in modifying state and national prescriptive authority legislation. 
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Sampling Methods/Participant Characteristics 
A convenience sample of APNs was recruited to respond to a survey posted on 
Survey Monkey. No compensation was offered to participants. To be included in the project, 
respondents must have had a valid license, professional credentials, and a minimum of a 
master’s degree in nursing or a DNP with course work in an advanced nursing area of 
practice. Anonymity of participants was be maintained. Participants were asked to respond 
critically and answer all questions. 
Confidentiality and Human Rights Protection 
Individuals meeting criteria were invited to participate. There was no formal signed 
consent but rather a letter of invitation to participate was sent with a returned survey response 
considered consent. Risks to participants were minimal and noted not to exceed those 
encountered in daily online interaction. There were no direct benefits to participants in this 
project; however, there were otherwise projected benefits to the nursing profession, the 
healthcare system, and society. To ensure anonymity, no identifying participant information 
was collected. Data obtained were secured online and password protected and will be kept 
online for a period of 5 years. The Walden University IBR provided an approval (# 05-27-
14-0349768) for the project before data were collected. 
Procedures 
Social networking was used for participant recruitment. Electronic invitations were 
sent to a convenient sample of APNs through email and Facebook. On Facebook, the link to 
the survey was posted for a period of 3 weeks on closed APN-specific pages that were only 
accessible to APNs. One-time feedback was completed based on individual use of the 
Survey Monkey tool.  
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Final Survey 
The final survey consisted of 10 questions in the following categories: 
respondent’s demographics, education, geographic area of practice, licensure and 
certification, scope of practice, and regulatory issues (see Appendix A). This paper 
includes a report of the findings from the 10 questions on the final survey. 
Data Analysis 
Descriptive statistics frequency distributions and percentages were used to analyze 
the data. Preset guidelines to qualify APNs to prescribe buprenorphine will in future be 
shared with APNs for their opinion and/or approval. These guidelines will be then revised 
and shared with policy makers. This was not a part of this project but thought for future 
consideration. 
The data obtained were analyzed using the Survey Monkey tool to summarize the 
quantitative results, while response to the draft guidelines was analyzed using content 
analysis to classify the open-ended results. The responses were analyzed in a common pool 
without consideration of practice setting or geographical location of the respondents. Results 
were then tabulated, and participants’ characteristics discussed while maintaining anonymity. 
Summary 
I created an online survey which was posted on Survey Monkey to collect data 
from a convenience sample of NPs. The data were analyzed to determine APN support and 
views of the buprenorphine prescription guidelines. The projected end product of the project 
is guidelines for NPs qualifications to prescribe buprenorphine legally that can be presented 
in the future to state legislatures and Congress as a starting point for amended legislation. 
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Section 4 will provide a summary of project findings and will include implications of the 
results and discussion of the limitations of the project. 
 
Section 4: Findings, Discussion, and Implications 
Introduction 
The purpose of the project was to describe the current trends in the continuing  
development of guidelines that would allow APNs to prescribe buprenorphine in treating 
opioid addiction on an outpatient basis. A 10-question survey was posted on APN specific 
pages on Facebook and e-mailed to 40 candidates. The link provided allowed access to the 
survey that was created and posted on survey monkey. The survey was  responded to by 96 
self-identified APNs from 32 different states within the United States.  About 1% practicing 
APNs was invited to participate. The results were also analyzed in aggregate convenience 
sampling method was applied, resulting in a total of 96  respondents who self-identified as 
APNs. 
The collected data were analyzed using Survey Monkey Tool results summary 
provided by survey monkey. Level of data analysis included individual responses (n = 96) 
from 32 different states. In some states, there was only one respondent or no respondents, 
while other states had several respondents (see Table 2). Participants were all anonymous 
and no identifying information was collected. 
Survey Results 
A total of 96 APNs responded to the questionnaire; 99% completed all the 
questions. The participants were drawn from all the 50 states of the U.S.; out of all the 
states. Members 32 of 50 states (64%) responded project 
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Answer choices Responses 
Female 91.67% 
Male 8.33% 
Figure 2. Classification of respondents by gender. 
Participant Characteristics 
Nearly all of the respondents were female (91.67%) and nearly 90% were NPs. 
Respondents were requested to identify their state of practice as well as their mental health 
practice experience. Out of the 96 respondents, 59.35% had psychiatry experience, with 
20.43% reporting greater than 5 years of psychiatry experience. Over 40% (40.85%) 
practiced as APNs but had no psychiatry experience.  
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Figure 3. Identifying actively licensed APN respondents 
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Figure 5. States represented by APNs/NPs respondents in the study. 
 
 
Table 2. Number of respondents by state n= 96 
Alabama – 1 
Alaska - 0 
Arizona – 1   
Arkansas - 2 
California - 3 
Colorado - 0 
Connecticut - 3 
Delaware – 2 
District of Columbia- 2 
Florida - 1 
Georgia - 2 
Hawaii - 0 
Idaho - 0 
Illinois - 5 
Indiana - 3 
Iowa - 2 
Kansas - 2 
Kentucky - 4 
Louisiana - 6 
Maine - 1 
Maryland - 5 
Massachusetts - 0 
Michigan – 4  
Minnesota - 0 
Mississippi - 1 
Missouri  - 0 
 
Wyoming - 0 
Montana - 0 
Nebraska - 1 
Nevada -0  
New Hampshire - 0 
New Jersey - 2 
New Mexico - 0 
New York - 8 
North Carolina - 5 
North Dakota - 0 
Ohio - 5 
Oklahoma - 1 
Oregon -0 
Pennsylvania - 4 
Rhode Island - 0 
South Carolina - 4 
South Dakota - 0 
Tennessee - 7 
Texas - 4 
Utah - 0 
Vermont - 0 
Virginia - 1 
Washington - 2 
West Virginia - 0 
Wisconsin - 1 
APN-NP Scope of Practice, Certification, and Employment 
Respondents were asked to rate how happy they were with their current scope of 
practice. The respondents rating of their scope of practice varied based on the state where they 
practice. The responses indicated that most APNs would like a wider scope of practice, although 
most expressed satisfaction with their current practice scope as listed in Figure 5. The differences 
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in NP-APN scope of practice exists because practice is regulated at the state level. According to 
the survey, 43.62% of respondents were only moderately happy with their scope of practice, 
11.70% were extremely happy, 32.98% reported being very happy, and 4.26% reported not 
being happy at all with their current scope of practice. In all, APNs seem happy with their scope 
of practice but are open to expanded roles. 
 
 
Figure 5. APN attitude about their current scope of practice. 
The respondents were also asked about the need for subspecialty certification in addiction 
medicine for APNs to prescribe buprenorphine. Well over half (63.54%) of the respondents felt 
that this was necessary, while the remaining 36.46% did not find this further certification 
necessary. 
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Figure 6. Respondents view on subspeciality certification. 
The survey revealed that 80.21% of the respondents hold a valid DEA number to 
prescribe narcotics in their state(s) of practice and are currently prescribing opiates (see Figure 
7). APNs with a valid DEA number will only be required to meet the stipulated requirements to 
obtain a special DEA number to prescribe buprenorphine. The APNs in states that still do not 
issue DEAs numbers will have to first obtain authority to prescribe narcotics. 
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Figure 7. APN respondents with a valid DEA license 
Of the 96 respondents, 59.14% reported that they had some mental health practice 
experience. The experience ranged from 1 to more than 5 years with a mode of more than 5 years 
of experience (see Figure 9). This would be beneficial in treating patients with addiction as most 
of the patients tend to report an underlying mental health problem. 
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Figure 8. Respondents’ mental health experience in years. 
When asked about their years of experience with mental health practice, only 20% 
of respondents had over 5 years of experience in mental health, while about 37% had some 
mental health experience. Nearly 41% (40.86%) of respondents reported no mental 
health practice experience. 
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Figure 9. APNs desire to prescribe buprenorphine 
Respondents were asked of their desire to prescribe buprenorphine. The majority of 
respondents (65.63%) expressed a desire to prescribe buprenorphine. Nearly 24% (23.96%) of 
respondents were unsure, and 1.04% had no desire to participate as buprenorphine providers. 
Interestingly, 9.33% of respondents thought otherwise about this issue without giving any 
specific information about their desires related to prescribing buprenorphine. 
NP-APN Education 
The survey included a question about the need to consider education level as a 
requirement in prescribing buprenorphine. The survey asked if APNs need to hold a DNP degree 
to prescribe buprenorphine for addiction treatment. Of the 96 respondents, only 13.54% agreed 
that APNs need to hold a DNP degree to prescribe buprenorphine, while 86.46% thought the 
degree was too new to be considered a requirement at this time. In reference to preparation for 
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NPs for this role, 98.96% of the respondents agreed that NPs should go through the same 8 
hour training that physicians complete to prescribe buprenorphine. 
 
 
 
 
Figure 10. Do APNs need a DNP degree to prescribe buprenorphine? 
Summary of Findings 
Impact on practice and action 
There is great variation in APN practice site, scope of practice, and prescriptive 
authority across the nation, while licensing requirements remain the same. It is clear that  
a uniform scope of practice across all states would simplify legislative changes at federal 
levels such as amendment of DATA 2000. 
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Most APNs who responded to the survey work in primary care, hold a valid DEA license 
to prescribe narcotics, and expressed an interest in prescribing buprenorphine for addiction 
treatment. This would increase accessibility to treatment for people addicted to opioids. 
APNs who participated in the study showed an interest in and support for expanded scope 
of practice. APNs are encouraged to transform this interest into political will and actively 
advocate for changes that will help expand their scope of practice. This is particularly 
necessary due to the current shortage of primary care providers in the wake of the introduction 
of the ACA. It is also important for APNs to foster a productive interprofessional relationship 
with other providers such as physicians and pharmacists, to lobby their support. 
Impact on future research.  
Findings from this study can be applied to future research that seeks to expand APN 
scope of practice. The end product of this study can also be used as a supporting document or 
guide to expand addiction treatment services. The policy brief developed may be presented to 
enlighten the policy makers on this issue and seek support. If adopted, the results of the project 
will have implications for nursing policy advocates nationally. 
Impact on social change.  
The expansion in the role of APNs in addiction treatment is likely to increase 
accessibility to care. This expansion will enable patients with opioid addiction to seek 
treatment and decrease the social injustices caused by addiction. In the future, the findings of 
this project will help decrease the societal, and criminal justice system burden, as well as the 
healthcare burden related to addiction. 
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Impact on NP education and certification 
One of the most difficult barriers in initiating NP/APN practice changes is the variable 
scope of NP-APN practice. I encourage APNs to lobby for uniform scope of practice to match 
the NP uniform education. A majority (63.54%) of the respondents agreed that APNs need 
special certification to prescribe buprenorphine while 36.46% objected to this requirement. 
This disagreement may lead to development of programs to provide subspecialty certification. 
There will be no need to develop a new 8-hour course for APNs as there is one already 
offered to physicians. The same course could be offered to qualified APNs seeking 
buprenorphine certification. 
Project strengths and limitations 
The project came at a time when scope of practice is generating a lot of attention from 
APNs, policy makers, and the healthcare community as a whole. The use of social media 
(Facebook) was one of the greatest strength of the study as a diverse sample of APN 
participants was reached with minimum effort. To ensure that participants were APNs, 
Facebook allowed for posting of the survey on profession specific pages where only members 
could access the survey and respond. 
Limitations and Recommendations for remediation of limitations 
Participation rates 
Although 32 out of 50 states and the District of Columbia were represented, some states 
had a very small number of respondents and other states were not represented at all. I would 
have liked to have all the states represented and may open the survey at a later date to increase 
participation numbers overall as well as geographic distribution. As a result of the pilot study, 
adjustments were made to the survey item responses to increase participation and for uniform 
responses. Rather than allowing free text, choice options were offered. The web survey did 
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not allow participants to reenter and complete the survey at a later time, but it intentionally 
was made very brief to allow completion within a short period of time. 
Analysis of Self 
As scholar 
This study enabled me to apply scholarship in practice through the identification of a 
clinical problem and work toward a solution. Through the study, many APNs were educated 
about the addiction field and the need for treatment accessibility. The issues addressed 
through the survey are significant to nursing practice and the end product of the project can be 
adopted or replicated to intervene in the opioid addiction epidemic in the U.S. today. 
Scholarship was also exhibited in this study through production of a document that can be of 
significance to the nursing profession. The survey elicited positive peer responses to my work, 
with some of the respondents calling this project very timely and necessary, while other 
colleagues marveled at my wealth of knowledge in the addiction field. 
As a scholar, this DNP student was able to identify the gaps in addiction treatment and 
collect as well as analyze appropriate data to develop a practice guideline for APNs interested 
in addiction treatment. The data analyzed were derived from practicing APNs and showed 
great promise for improved access and treatment of opiate addictions if prescriptive 
authority were to be expanded. 
As practitioner 
Many medical providers encounter patients battling addiction. The study incorporated 
solutions that respond to the needs of the family, existing culture, and the effects that addiction 
has on the community. More significantly, through the eyes of APNs the study highlighted 
scope of practice issues while providing possible solutions. 
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As a practitioner, I conducted a comprehensive assessment of addiction and its effects on 
individuals and the society as a whole. The investigation involved looking at individual 
patients, families, communities, the healthcare system, and the criminal justice system to 
determine the burden of addiction and establish the need for expanded treatment options. 
As project developer 
In this project, I assumed the role of an advocate for healthcare policy change. The 
project looked at DATA 2000 and the need to remove the barriers to treatment associated with 
this policy. The policy was analyzed from the perspective of patients, nurses, other 
professionals, and communities to determine the need for change. The project’s goal was to 
collect data in support of establishing guidelines that can be used to modify existing policy to 
remove barriers to treatment while increasing access to addiction services and reducing 
financial burden associated with addiction disparity. The final product will be used in the future 
to influence policy makers to initiate change. 
  
What does this project mean for future professional development? 
During this DNP project, data were collected in support of the expanded role of APNs 
in addiction treatment. The findings of this capstone project will significantly contribute to 
evidence-based nursing in addiction treatment and will provide a complete or partial solution 
to the problem of opioid addiction, which is currently an epidemic in the U. S. The guidelines 
that were created through this project, if adopted nationally, will significantly ease the 
transition of APNs into the role of buprenorphine prescribers for opiate addiction treatment. 
The project revealed that APNs have an interest in the use of buprenorphine for treatment 
of opioid addiction as revealed by their responses to the survey. As a result of the project, 
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guidelines were developed that will enable APNs to prescribe buprenorphine. For APNs to 
qualify to prescribe buprenorphine for addiction treatment, they must 
1. hold a current unrestricted state nursing license in the state where they desire to 
practice, 
2. hold a valid Drug Enforcement Administration (DEA) and CDS Certificate, 
3. have no current or previous narcotic or narcotic diversion charges against their license, 
4. complete not less than 8 hours of training currently completed by qualified physicians, 
5. establish a supervising physician with a completed and approved attestation 
to collaborate, 
6. agree to stay current by completing specified Continuing Medical Education (CMEs) 
annually, and 
7. have completed a master’s degree in nursing. 
  
Policy options/solutions 
Three options for implementing changes to DATA 2000 are 
partial change - expand DATA 2000 to allow only APNs who meet the speculated 
regulations and have a subspecialty certification to prescribe buprenorphine under the 
supervision of a “qualified physician,” 
radical change - amend DATA 2000 to allow APNs who meet the speculated 
regulations and hold a subspecialty certification to independently to prescribe 
buprenorphine, or 
maximum change - allow all APNs who have shown interest in prescribing 
buprenorphine, meet the set guidelines, and have completed the required training (not less than 
8 hours to independently prescribe buprenorphine) to do so. 
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Summary 
Using social networking as an avenue to reach APNs proved very interesting and 
effective. It provided a clear insight into the accessibility of participants through the right 
avenue. One post was accessed by a large number of APNs, which is more efficient than 
sending numerous e-mails. Through the pilot survey, I gained insight into how to 
simplify a survey so that it would be constructed to collect the necessary data and 
facilitate participation. 
Several organizations outlined in this study support the need to utilize APNs to the 
fullest scope of their education. The nursing profession has continuously presented evidence 
of the high competency of APNs in practice but the profession still meets 
several barriers to practice. These barriers include the DATA 2000 policy. Nurses and nursing 
organizations are encouraged to channel energy into political advocacy to help initiate positive 
changes for the nursing profession. The nursing profession has over the years made advancements 
in education and practice, which is mirrored in the excellent service provided by APNs. APNs 
represent a dominant giant in healthcare, and they are key players in patient care, especially 
primary care. To meet the increased patient needs as a result of the ACA, APNs must cultivate 
effective lobbying power to initiate change. 
APNs are motivated to assume roles in healthcare to help improve the quality of life for 
patients. Although motivated, APNs are still concerned about the effects and control other 
professions, especially physicians, have on their scope of practice. The project revealed that 
APNs are not opposed to collaboration with these professionals but they merit the autonomy to 
practice in a wider scope in line with their training. One APN in the study indicated that the 
DATA 2000 amendment is an uphill battle for APNs because buprenorphine prescription is a 
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significant source of income for physicians and competition is not welcomed. This position 
does not address the large underserved population of patients who would benefit from an 
expansion of APNs’ scope of practice. 
Based on the data collected and analyzed in this study, APNs understand that this is a 
good time for healthcare delivery change and that there is a great need in addiction treatment. 
APNs are willing to complete further training to meet the required qualifications to prescribe 
buprenorphine. In the U.S., amendment of DATA 2000 as a step toward increased recognition of 
the nursing profession as well as effective utilization of APNs. Change of the Act will also 
increase access to addiction treatment, improve the lives of individuals and families battling 
addiction, decrease disparities, and decrease the burden to the healthcare and criminal justice 
systems. The ultimate goal of this project is to allow APNs to provide comprehensive care to 
patients and families with substance abuse issues. 
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Section 5: Scholarly Product (Policy Brief)  
Introduction 
The scholarly product for this project is a policy brief. The goal of this policy brief is 
to present the research and data collected in this project to policy makers to initiate change 
and amend Drug Addiction Treatment Act of 2000 (DATA 2000). The policy brief provides 
recommendations that are feasible, acceptable to policy makers, cost effective, and meet the 
public needs. Using the policy brief developed through this project, I will seek opportunities 
to contact policy makers whose values are in line with the proposed change in order to rally 
their support and provide them with the document as a guide to the necessary policy changes 
(Milstead, 2011). 
Drug Addiction Treatment Act (DATA 2000), 13 Years Later 
The Office of National Drug Control Policy (ONDCP), (2011) agreed that substance 
abuse rates have hit epidemic levels in the United States. Abuse of both illicit and prescription 
drugs have been the cause of many deaths and hospitalizations costing Americans billions of 
healthcare dollars. Substance abuse directly affects the individual users, their families, and the 
general community and leads to a financial burden in healthcare costs, lost productivity and 
justice system related costs. Substance abuse contributes to social, physical, justice, 
psychological, and public health problems (O'Connor, 2010). The National Institute of Drug 
Abuse (NIDA) estimated that approximately 95% of active substance abusers are in denial or 
unaware of their problem. Only 273,000 (18.6%) of active substance users are actively enrolled 
in treatment ((NIDA, 2012). DATA 2000 has limited providers who can prescribe 
buprenorphine denying patients access to life-saving treatment (Lofwall & Havens, 2012).  
 
46 
 
                             Current politics of the issue 
Buprenorphine is currently the only Federal Drug Administration (FDA) approved 
medication for the treatment of opioid addiction in a primary care office. Buprenorphine 
treatment is regulated under the federal DATA 2000, established under Public Law 106-310, 
Title XXXV, Sections 3501 and 3502. This legislation allows “qualified physicians” to treat 
opioid addiction with buprenorphine in office-based settings (Roose et al., 2008). DATA 2000 
does not allow Advance Practice Nurses (APNs) to prescribe buprenorphine; thereby, excluding 
nurses who already hold a valid Drug Enforcement Administration (DEA) license and are 
authorized to prescribe Schedules III, IV, and V controlled substances (O'Connor, 2010; Roose 
et al., 2008).  
                            Current policy level 
In April 2012, the Secretary of Health and Human Services noted the need for more 
buprenorphine providers. A waiver was issued by SAMHSA to amend the DATA 2000 
regulations, exempting "qualified physicians" from the rules applied to Outpatient Treatment 
Programs (OTPs). The waiver allowed providers to use buprenorphine for the treatment of 
addiction in office-based practice (Lofwall & Havens, 2012). There was no mention of 
inclusion of APNs to ease the shortage of providers and close the treatment gap. 
The IOM Future of Nursing Practice (IOM; 2010) identified the need for APNs to be 
better utilized across healthcare settings and patient populations. APN providers have 
demonstrated that they are valuable across the healthcare spectrum as generalists as 
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well as specialists (Roose et al., 2008). The IOM also emphasized coordinated and cost-
effective care, and noted that APNs have tended more than other providers to establish 
practices in traditionally underserved areas. The IOM agreed that there are regulatory 
restrictions that currently prevent APNs from being utilized to their potential. Policies like 
DATA 2000 have barred APNs from office-based addiction treatment using buprenorphine. 
The IOM found that most of these policies are “meaningless/needless and without rationale” 
(IOM, 2010). The authors identified the need for policy change that included outdated policies 
like DATA 2000. 
Building Consensus 
DATA 2000 is an old policy that has failed to transition with the changes in healthcare 
needs and provider roles. The call for change is focused on factual information and studies of 
APN quality of practice. The roles and education of NPs have greatly advanced over the last 13 
years. Stakeholders invested in the policy change include community leaders, professional 
organizations, patients, practicing APNs, and Boards of Nursing. 
APNs were surveyed nationally using social media to identify APNs’ perceptions of 
DATA 2000 in the U.S. restricting prescriptive authority associated with buprenorphine for 
outpatient opiate addiction treatment. Opinions regarding necessary APN education, expertise, 
and qualifications needed to prescribe buprenorphine were elicited. The project also sought to 
elicit APNs’ feedback on draft guidelines to qualify APNs to prescribe buprenorphine and 
their general personal interest in prescribing buprenorphine. 
48 
 
 
The stakeholders 
In favor of amendment of DATA 2000 are stakeholders include community leaders, 
professional organizations, patients, practicing APNs, and Boards of Nursing. The 
International Nurses Society on Addictions (IntNSA), The Association of Nurses in AIDS 
Care (ANAC) and the IOM agree on the need to maximize the potential of APRNs. They all 
agree that APRNs’ skills, knowledge, and education have grown tremendously within the last 
10 years, yet their scope of practice remain barred by old policies like the 13-year-old DATA 
2000. IntNSA (2011) identified that DATA 2000 is a barrier in the treatment and recommend 
for Amendment. IntNSA reported that for the provision of accessible, safe, buprenorphine 
treatment for opioid addiction treatment, the Drug Addiction Treatment Act of 2000 (DATA 
2000) needs to be amended to allow qualified APNs who meet set criteria and express desire 
to prescribe buprenorphine in OPTs. ANAC (2011) supported the need to amend DATA 2000 
to allow qualified APNs to prescribe buprenorphine in addiction treatment. They continue to 
note that this change in policy will increase access to treatment and reduce the current 
addiction-related burden. Many APNs already have independent prescriptive authority, a DEA 
license to prescribe narcotics, the state license to practice, and prescribe other opioids. 
Recommendations/guidelines 
Based on the literature, the APN survey responses, and stakeholder support, the 
following guidelines are recommended for APNs to qualify to prescribe buprenorphine for 
addiction treatment. APNs must 
1. hold a current unrestricted state nursing license in the state where they desire to 
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practice, 
2. hold a valid Drug Enforcement Administration (DEA) and CDS Certificate, 
3. have no current or previous narcotic or narcotic diversion charges against their license, 
4. complete not less than eight hours of training currently completed by 
qualified physicians, 
5. establish a physician with a completed and approved attestation to collaborate, 
6. agree to stay current by completing specified Continuing Medical Education 
(CMEs) annually, and 
7. have completed a minimum of a master’s degree in nursing. 
Policy options/solutions 
Three options for implementing changes to DATA 2000 are 
1. partial change - expand DATA 2000 to allow only APNs who meet the speculated 
regulations and have a subspecialty certification to prescribe buprenorphine under the 
supervision of a “qualified physician," 
2. radical change - amend DATA 2000 to allow APNs who meet the speculated 
regulations and hold a subspecialty certification to independently to prescribe 
buprenorphine, and 
3. maximum change - allow all APNs who have shown interest in prescribing 
buprenorphine, meet the set guidelines, and have completed the required training 
(not less than 8 hours to independently prescribe buprenorphine) to do so. 
The pros and cons of DATA 2000 expansion 
The proposed amendment of DATA 2000 will grant APNs ability to prescribe 
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buprenorphine for the treatment of opioid addiction. This change will result in increased access 
to buprenorphine treatment for those affected by addiction (Roose et al., 2008). Patients will be 
able to get treatment through their primary care provider, affording them the ability to start 
treatment soon as they seek help (Lofwall & Havens, 2012). The increased accessibility will 
result in a decline in financial and healthcare costs and justice system burden caused by opioid 
addiction (O'Connor, 2010). On the other hand, the more patients enrolled in treatment and who 
receive buprenorphine, the more likely there will be an increase in buprenorphine diversion. 
Providers, whether physicians or APNs, should be knowledgeable of this risk and initiate 
measures to decrease the possibility of diversion (Arfken et al., 2010). 
Conclusion 
The amendment of DATA 2000 to allow APNs to prescribe buprenorphine will 
relieve burdens to the healthcare and justice systems and provide affordable, quality, 
accessible addiction treatment. APNs are willing and motivated to prescribe buprenorphine 
and they are ready to meet guidelines established for safe and efficient prescribing. It is now 
time for lawmakers to take another look at DATA 2000 and make the long overdue 
amendments. 
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                                             Appendix A: Survey Tool 
Expanding APN scope of practice in addiction treatment. 
 1. What is your gender?  
Female Male  
 2. Are you currently licensed as a Nurse Practitioner? 
Yes No  
 3. In what state or U.S. territory do you practice?  
 4. Do you hold a valid DEA number/ authority to prescribe narcotics in your state?  
Yes, I do No, I do not  
 5. How happy are you with your current scope of practice? 
Extremely happy 
Very happy 
Moderately happy 
Slightly happy 
Not at all happy 
 
 6. Do you have addiction or mental health experience? 
None less than 1 year 
1-2 years 
2- 5 years 
More than 5 years 
 
Other (please specify)  
 7. Should Nurse practitioners be authorized to prescribe buprenorphine for addiction treatment?  
Yes No Maybe  
Other (please specify)  
 8. Should Nurse Practitioners be required to hold subspecialty board certification in addiction 
medicine?  
Yes No  
 9. Should Nurse practitioners complete the same 8 hours training required for physicians to 
prescribe buprenorphine?  
Yes No  
 10. Should Nurse Practitioners be required to hold a DNP degree to prescribe buprenorphine?  
Yes No  
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Education. 
                                                             Curriculum Vitae 
Dorothy L. Were, RN, FNP-BC 
Telephone: cell: 410- 200-5042. 
Email: lowere2000@yahoo.com / dwere@homephysicians.com  
Objective: Seeking a challenging position in a company where my extensive medical, 
professional, practical experience, and dedication will be fully utilized while providing 
age specific care to patients and their families. 
Profile: 
1. Provide care as sole primary care provider in the practice, returning patient phone calls, 
responding to incoming faxes for DME, medical supplies and equipment and 
completing FMLA paperwork, MVA disability forms, and death certificates. 
2. Knowledge of ICD9/ ICD 10 coding. 
3. Familiar with management of both acute and chronic diseases. 
4. Understanding of health insurance: local providers, general plan types, and 
terminology. 
5. Deep knowledge of the federal, state and local laws regarding patient and 
treatments as well as advance directives. 
6. Excellent assessment, communication and clinical skills. 
7. Collaborate with other providers to maximize patient care. 
8. Experience with EHR documentation. 
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DNP - Walden University 2011 to date 
MSN - Coppin State University (2009) 
BSN - Coppin State University (2004) 
Professional Experience. 
2013 to date: Five Star Physicians 
On call provider for nursing home and inpatient services. 
3/2012 to date: Chesapeake Home Physicians (Primary care provider) 
- Provide acute and chronic care to home bound patients in the comfort of their homes 
and assisted living facilities. Order diagnostic services, review results. 
- Oversee care of hospice patients within their primary settings. 
2010 – 2012: Turning Point Clinic (Associate Medical Director) 
- Provided medical services including taking a history and physical examination for both 
the primary care program and the narcotic replacement therapy program. 
2009 – 2012: Westside Medical Group - Family practice (Associate Medical Director) 
-Performed comprehensive physical assessment of patients and immunizations. 
-Established medical diagnosis and managed acute and chronic health conditions. 
-Ordered, performed, and interpreted diagnostic testing including laboratory tests, EKGs, 
and radiographic studies. 
-Completed sports physicals, school physicals, and DOT certifications. 
2008 – 2009: Student Nurse Practitioner – Windsor Medical Center. 
2009 – 2011: Mt. Washington Pediatrics NICU RN 
2008 - 2013: Access Nursing Services 
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-Completed several per diem assignments and contracts at different facilities including: 
-Johns Hopkins Medical (Adolescence Medicine contract) - 1/2011 to 8/2011 - 
University of Maryland Medical center (Pediatrics contract) - 11/2009 to 04/2010 - 
Union memorial hospital (Adult Med Surgical Nursing contract) - 3/2009 to 12/2009 
-Franklin Square hospital (Pediatrics contract) - 01/ 2008 to 03/2009 
-Kennedy Krieger Children’s Institute, Baltimore, MD, RN II - 2005 to 2008 
Credentials Certifications 
CRNP, FNP-BC BLS/ PALS 
Registered Nurse MD CDS/DEA 
Awards: Excellence in clinical Practice Coppin State class of 2009. 
Volunteer experience: 
Founder and CEO IPLEA international. Organized and led a team of healthcare 
professionals on 3 medical missions to Kenya 2011, 2012, and 2014 as the only 
prescriber and head medical provider of the team. 
Professional Organizations: 
Maryland Nurses Association 
Nurse Practitioners Association of Maryland 
References available upon request. 
